Introduction
The proto-oncogene, bcl-2, was identified as a result of its involvement in the t(14:18) chromosomal translocations associated with human follicular lymphomas (Bakhshi et al. 1985 , Cleary & Sklar 1985 , Tsujimoto et al. 1985 . Subsequently, it was demonstrated that overexpression of the protein product, Bcl-2, prolonged cell survival in the absence of growth factor (Vaux et al. 1988 ) and repressed programmed cell death in hemopoietic cells (Hockenbery et al. 1990 ). Numerous ensuing experiments have shown that Bcl-2 can prevent or markedly attenuate cell death induced by a wide variety of stimuli including many drugs, oxygen radicals, viral agents and heat shock (reviewed by Reed 1994). Bcl-2 has also been shown to suppress cell death in various neuronal cell types following the withdrawal of neurotrophic factors (Garcia et al. 1992 , Allsopp et al. 1993 , Batistatou et al. 1993 , Mah et al. 1993 or axonal injury (Dubois-Dauphin 1994) . These data, as well as the finding that human Bcl-2 can prevent programmed cell death in the nematode Caenorhabditis elegans (Vaux et al. 1992) and is homologous to the nematode cell survival gene, ced-9 (Hengartner & Horvitz 1994) have firmly established Bcl-2 as an integral regulator of a cellular mortality.
Recent studies have shown that Bcl-2 is a member of a gene family that is conserved throughout evolution (reviewed by Reed 1994). Functionally, Bcl-2-like proteins fall into two categories. Most members of the family inhibit cell death whereas the mammalian Bcl-2 homologues, Bax and Bcl-Xs counter the death-repressing activity. This may be accomplished via homo-or heterodimerization (Oltvai et al. 1993) . For example, Bcl-2 can heterodimerize with Bax and the ratio of Bcl-2 to Bax determines survival or death following apoptotic stimuli (Oltvai et al. 1993) . Bcl-2 can also heterodimerize with Bcl-Xs (Sato et al. 1994) .The latter interaction appears to leave the cell death-promoting functions of Bax unopposed (Sato et al. 1994) .Thus, a cell's intrinsic ratio of death repressor to death promoter molecules may subserve the selective nature of Bcl-2 action (Sentman et al. 1991 , Allsopp et al. 1993 , Behl et al. 1993 , Selvakumaran et al. 1994 .
Although the exact mechanism(s) utilized by Bcl-2 to prevent cell death from various stimuli is not known, one suggestion has been that Bcl-2 mitigates the effects of reactive oxygen species and thus protects cells from oxidative stress (Hockenbery et al. 1993 , Kane et al. 1993 ). This hypothesis is of particular interest in central nervous system (CNS) disorders in which oxidative stress is thought to con-
